Final answer:
Sodium glucose linked transporter (SGLT2) inhibitors primarily target the kidneys, preventing glucose reabsorption and helping to lower blood sugar levels in people with diabetes.
Step-by-step explanation:
The primary target of Sodium glucose linked transporter (SGLT2) inhibitors is the kidneys. SGLT2 inhibitors are a class of medications used primarily to treat type 2 diabetes. These medications work by preventing the reabsorption of glucose in the kidney, resulting in more glucose being excreted in the urine. SGLT2 is responsible for the reabsorption of the majority of the glucose filtered by the kidneys. By inhibiting this process, SGLT2 inhibitors help lower blood glucose levels in individuals with diabetes.